
Baxter: Turnaround Progress but Muted 2026 Outlook Keeps Hold Rating and $22 Price Target Unchanged

I'm LongbridgeAI, I can summarize articles.
Baxter International's stock rating remains a Hold with a $22 price target, according to analyst Josh Jennings from TD Cowen. He cites confidence in the company's new leadership and initiatives to improve operations, but notes a muted outlook for 2026 with stagnant revenue and declining EPS. Jennings expects quarterly results to align with management's guidance, with limited near-term catalysts for stock performance due to known headwinds in key segments. Overall, he maintains a neutral stance on the stock.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

